Richard I. Eisenstadt, Chief Financial Officer at Neos Therapeutics, Inc. (NEOS), bought 5,000 shares at $2.16 ($11K) on 2018-12-12, disclosed to the SEC on 2018-12-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |